With an estimated 595 million people worldwide living with osteoarthritis, chronic joint pain remains one of modern medicine’s most pervasive challenges. For millions of patients, the treatment pathway feels like a dead end: temporary pain relievers that risk stomach and kidney health, physical therapy that plateaus, and repeated cortisone injections that offer diminishing returns.

When conservative options fail, patients are often told to simply “wait until it gets bad enough” for total joint replacement surgery.

A new peer-reviewed critical review published in Cureus argues that it is time to rewrite that algorithm. Co-authored by Dr. Bobby N. Koneru, MD, FASTRO, Chief Medical Officer and co-founder of JointGlow, alongside leading colleagues from the American College of Radiation Oncology (ACRO), the paper evaluates decades of clinical evidence. It proposes formally integrating Low-Dose Radiotherapy (LDRT) into contemporary care pathways for osteoarthritis.

Here is what the latest research shows and why it matters for patients seeking lasting, non-surgical relief.

Key Takeaways from the Review

1. Decades of Evidence Across Europe

While LDRT is gaining rapid momentum in the United States, Dr. Koneru and his co-authors emphasize that it has been a front-line orthopedic standard of care in Europe, especially Germany, for more than half a century. International registries and clinical trials consistently report meaningful, durable pain relief and improved joint mobility for patients with degenerative joint disease.

2. An Exceptional Safety Profile

One of the primary goals of the review is addressing common patient hesitations around radiotherapy. The authors emphasize that LDRT utilizes minute, tightly localized doses calibrated strictly to calm inflammation without destroying tissue. For example, LDRT for knee osteoarthritis results in an effective dose comparable to a routine abdominopelvic CT scan. Systemic side effects do not occur, making it a viable option for patients who cannot tolerate oral medications or undergo invasive surgery.

3. Closing the “Treatment Gap”

The paper advocates positioning LDRT as an evidence-based bridge between conservative medical management and surgical joint replacement. Instead of allowing joints to deteriorate while relying on repeated steroid shots that can accelerate cartilage loss, LDRT intervenes biologically to reset the joint environment.

How LDRT Works at the Biological Level

Osteoarthritis is driven by ongoing, low-grade cellular inflammation. Pro-inflammatory white blood cells invade the joint lining, producing cytokines that irritate nerves, fuel swelling, and wear down cartilage.

LDRT changes the behavior of those cells:

  • Flips immune signaling: Encourages overactive immune cells to switch from a pro-inflammatory state to a healing, anti-inflammatory state.
  • Reduces swelling and irritation: Suppresses the inflammatory cascade to relieve pain at its microscopic root.
  • Protects joint architecture: Unlike repeated steroid injections, LDRT does not weaken tendons or degrade surrounding cartilage.

The JointGlow Difference: Non-Surgical Care Designed for Mobility

Under the clinical guidance of physician leaders like Dr. Koneru, JointGlow delivers targeted Low-Dose Radiotherapy using advanced technology in brief, comfortable outpatient visits:

  • Zero surgery: Completely non-invasive external treatment.
  • Zero needles: No painful joint injections or fluid aspiration.
  • Zero recovery time: Sessions take about 10 minutes, so that you can return immediately to work, family, or your active routine.
  • Insurance-covered: Medicare Part B (Excludes Medicare Advantage) and most major private insurance plans cover LDRT.

The evidence is clear: you do not have to settle for masking joint symptoms while waiting for major surgery.

Explore Non-Surgical Joint Relief

Are you struggling with persistent knee, hip, shoulder, or hand pain that hasn’t responded to traditional care?

Schedule a consultation with JointGlow today to see whether Low-Dose Radiotherapy is the right next step for your joint health.